{"issuance_frequency":"","notes_translated":{"fr":"Nous présentons ici les données les plus récentes sur les délais de production des anticorps contre le SRAS-CoV-2, notamment la longévité des anticorps, ainsi que la production et la détection des anticorps neutralisants et nous formulons des conseils pratiques destinés aux laboratoires de microbiologie clinique afin que ces derniers vérifient les tests sérologiques commerciaux et choisissent les algorithmes de test appropriés pour leurs populations locales.","en":"We present the most up-to-date data on SARS-CoV-2 antibody timelines, including the longevity of antibodies, and the production and detection of neutralizing antibodies and provide practical guidance for clinical microbiology laboratories to both verify commercial serology assays and choose appropriate testing algorithms for their local populations."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"5b59b8bf-5758-4f69-8c95-0393d633fc25","metadata_created":"2021-05-28T17:31:18.967239","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-05-28T17:31:18.967248","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-05-28","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["RMTC","Relevé des maladies transmissibles au Canada","COVID-19","SRAS-CoV-2","coronavirus","pandémie","Canada","tests sérologiques","algorithmes de sérologie"],"en":["CCDR","Canada Communicable Disease Report","COVID-19","SARS-CoV-2","coronavirus","pandemic","Canada","serological testing","serology algorithms"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Guide pour les laboratoires pour le dépistage du SRAS-CoV-2","en":"Laboratory guidance for SARS-CoV-2 testing"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"5b59b8bf-5758-4f69-8c95-0393d633fc25","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"6944c78f-a704-4cfe-b5b1-2c27a7eeeaf7","related_relationship":"","name_translated":{"fr":"Guide pour les laboratoires pour le dépistage du SRAS-CoV-2","en":"Laboratory guidance for SARS-CoV-2 testing"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Laboratory guidance for SARS-CoV-2 testing","language":["en"],"created":"2021-05-28T17:31:19.049752","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-4-april-2021/laboratory-guidance-sars-cov-2-testing.html","last_modified":null,"position":0,"revision_id":"af913933-3a0b-4251-8299-4551e3547569","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"5b59b8bf-5758-4f69-8c95-0393d633fc25","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"0f55637a-4bd6-48cd-a281-96dcd2ccd1bc","related_relationship":"","name_translated":{"fr":"Guide pour les laboratoires pour le dépistage du SRAS-CoV-2","en":"Laboratory guidance for SARS-CoV-2 testing"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Laboratory guidance for SARS-CoV-2 testing","language":["fr"],"created":"2021-05-28T17:31:19.049758","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-4-avril-2021/guide-laboratoires-depistage-sras-cov-2.html","last_modified":null,"position":1,"revision_id":"af913933-3a0b-4251-8299-4551e3547569","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2021-04-29 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"5b59b8bf-5758-4f69-8c95-0393d633fc25","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"We present the most up-to-date data on SARS-CoV-2 antibody timelines, including the longevity of antibodies, and the production and detection of neutralizing antibodies and provide practical guidance for clinical microbiology laboratories to both verify commercial serology assays and choose appropriate testing algorithms for their local populations.","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Laboratory guidance for SARS-CoV-2 testing","revision_id":"af913933-3a0b-4251-8299-4551e3547569"}